TWST vs. ASPN
TWST (Twist Bioscience Corporation) and ASPN (Aspen Aerogels, Inc.) are both stocks. TWST operates in Diagnostics & Research (Healthcare), while ASPN operates in Building Products & Equipment (Industrials). Over the past 5 years, TWST returned -5.74%/yr vs -34.24%/yr for ASPN. Their 0.34 correlation means their historical movements had little consistent relationship.
Performance
TWST vs. ASPN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TWST achieves a 188.62% return, which is significantly higher than ASPN's 63.60% return.
TWST
- 1D
- 0.24%
- 1M
- -7.75%
- 6M
- 122.91%
- YTD
- 188.62%
- 1Y
- 171.82%
- 3Y*
- 58.73%
- 5Y*
- -5.74%
- 10Y*
- —
- ALL TIME*
- 28.65%
ASPN
- 1D
- 2.66%
- 1M
- -17.03%
- 6M
- 37.39%
- YTD
- 63.60%
- 1Y
- -39.08%
- 3Y*
- -17.28%
- 5Y*
- -34.24%
- 10Y*
- -0.71%
- ALL TIME*
- -6.88%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $4.81M | $4.87M | $8.20M | |
| $113.24M | $125.54M | $135.60M |
TWST vs. ASPN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
TWST Twist Bioscience Corporation | 188.62% | -31.74% | 26.07% | 54.81% | -69.23% | -45.23% | 572.81% | -9.05% | 77.62% |
ASPN Aspen Aerogels, Inc. | 63.60% | -76.18% | -24.71% | 33.84% | -76.32% | 198.32% | 115.08% | 264.32% | -45.52% |
Correlation
The correlation between TWST and ASPN is 0.33, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.33 |
Correlation (3Y) Balances recent behavior with more history. | 0.37 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.42 |
Correlation (All Time) Calculated using the full available price history since Oct 31, 2018 | 0.34 |
Fundamentals
TWST:
$5.70B
ASPN:
$383.72M
TWST:
-$1.33
ASPN:
-$1.36
TWST:
13.65
ASPN:
1.66
TWST:
12.41
ASPN:
1.79
TWST:
$409.48M
ASPN:
$230.26M
TWST:
$213.23M
ASPN:
$27.46M
TWST:
-$58.23M
ASPN:
-$59.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TWST vs. ASPN — Risk / Return Rank
TWST
ASPN
TWST vs. ASPN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Twist Bioscience Corporation (TWST) and Aspen Aerogels, Inc. (ASPN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TWST | ASPN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.95 | ||
| Sortino ratioReturn per unit of downside risk | +3.00 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.00 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 6.15 | -0.56 | +6.71 |
| Martin ratioReturn relative to average drawdown | 14.14 | -0.83 | +14.97 |
Loading charts...
Drawdowns
TWST vs. ASPN - Drawdown Comparison
The maximum TWST drawdown since its inception was -94.48%, roughly equal to the maximum ASPN drawdown of -95.96%. Use the drawdown chart below to compare losses from any high point for TWST and ASPN.
Loading charts...
Drawdown Indicators
| TWST | ASPN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.48% | -95.96% | +1.48% |
Max Drawdown (1Y)Largest decline over 1 year | -28.27% | -70.86% | +42.59% |
Max Drawdown (3Y)Largest decline over 3 years | -58.97% | -91.90% | +32.93% |
Max Drawdown (5Y)Largest decline over 5 years | -91.54% | -95.96% | +4.42% |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.96% | — |
Current DrawdownCurrent decline from peak | -55.98% | -92.73% | +36.75% |
Average DrawdownAverage peak-to-trough decline | -58.11% | -56.82% | -1.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.27% | 47.63% | -35.36% |
Volatility
TWST vs. ASPN - Volatility Comparison
The current volatility for Twist Bioscience Corporation (TWST) is 19.68%, while Aspen Aerogels, Inc. (ASPN) has a volatility of 21.62%. This indicates that TWST experiences smaller price fluctuations and is considered to be less risky than ASPN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TWST | ASPN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.68% | 21.62% | -1.94% |
Volatility (6M)Calculated over the trailing 6-month period | 50.21% | 68.21% | -18.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.91% | 93.48% | -24.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.24% | 87.38% | -11.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.24% | 75.19% | +3.05% |
Dividends
TWST vs. ASPN - Dividend Comparison
Neither TWST nor ASPN has paid dividends to shareholders.
Financials
TWST vs. ASPN - Financials Comparison
This section allows you to compare key financial metrics between Twist Bioscience Corporation and Aspen Aerogels, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TWST vs. ASPN - Profitability Comparison
TWST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Twist Bioscience Corporation reported a gross profit of 57.12M and revenue of 110.72M. Therefore, the gross margin over that period was 51.6%.
ASPN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Aspen Aerogels, Inc. reported a gross profit of 4.28M and revenue of 37.88M. Therefore, the gross margin over that period was 11.3%.
TWST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Twist Bioscience Corporation reported an operating income of -45.86M and revenue of 110.72M, resulting in an operating margin of -41.4%.
ASPN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Aspen Aerogels, Inc. reported an operating income of -20.83M and revenue of 37.88M, resulting in an operating margin of -55.0%.
TWST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Twist Bioscience Corporation reported a net income of -44.02M and revenue of 110.72M, resulting in a net margin of -39.8%.
ASPN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Aspen Aerogels, Inc. reported a net income of -23.69M and revenue of 37.88M, resulting in a net margin of -62.5%.
Frequently Asked Questions
TWST and ASPN have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASPN has higher volatility (21.62%) compared to TWST (19.68%). In terms of maximum drawdown, TWST dropped -94.48% vs ASPN's -95.96%.
TWST currently has the higher Sharpe Ratio (2.53 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TWST and ASPN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer